Sign In
16 Feb 2009 17:39
ο»Ώ
Ark Therapeutics Group plc
2009
Notification of Major Interests in Shares
Β
1Β Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
ARK THERAPEUTICS GROUP PLC
2.Β Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights: (x)
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which votingΒ rights are attached ( )
An event changing the breakdown of voting rights: ( )
Other ( )
3.Β Full name of person(s) subject to the notification obligation:
The Wellcome Trust Limited as trustee of the Wellcome Trust
4.Β Full name of shareholder(s) (if different from 3):
As above
Β
5.Β Date of the transaction and date on which the threshold is crossed or reached if different:
10 February 2009
6.Β Date on which issuer notified:
12 February 2009
Β
7.Β Threshold(s) that is/are crossed or reached:
Breached 3% of issued shares
8.Β Notified details:
A:Β Voting rights attached to shares
Class/type of shares: OrdinaryΒ
GB0034251727
Situation previousΒ to the triggering transaction:
Number of shares: Below 3%
Number of voting rights: Below 3%
Resulting situation after the triggering transaction:
Number of shares:
Direct: 7,244,400
Number of voting rights:Β
Direct: 7,244,440
Indirect:
% of voting rights:
Direct: 3.53%
Indirect:
B:Β Financial Instruments: N/A
Resulting situation after the triggering transaction:
Type of financial instrument:
Expiration date:
Exercise/conversion period/date:
Number of voting rights that may be acquiredΒ
if the instrument is exercised/ converted:
% of voting rights:
Total (A+B):
Number of voting rights: 7,244,400
% of voting rights: 3.53%
Β
9.Β Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
N/A
Proxy Voting:
10.Β Name of the proxy holder:
N/A
11.Β Number of voting rights proxy holder will cease to hold:
Β 12.Β Date on which proxy holder will cease to hold voting rights:
13.Β Additional information:
14.Β Contact name:
Mr Kim Cini
15.Β Contact telephone number:
0207 611 8665
16. Contact name and telephone at issuer:
Martyn Williams
Company Secretary
Ark Therapeutics Group plc
020 7388 7722
16 February 2009
Follow the stocks
